Armistice Capital’s Axonics, Inc. Common Stock AXNX Stock Holding History

Armistice Capital’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-388,000	Closed	-$21.7M	–	193
2021 Q4	$21.7M	Buy	+388,000	New	+$23.7M	0.36%	64
2021 Q3	–	Sell	-378,000	Closed	-$24M	–	161
2021 Q2	$24M	Sell	378,000 -40,000	-10%	-$2.36M	0.43%	63
2021 Q1	$25M	Buy	418,000 +170,000	+69%	+$9.24M	0.57%	50
2020 Q4	$12.4M	Buy	248,000 +108,000	+77%	+$5.07M	0.42%	59
2020 Q3	$7.15M	Buy	+140,000	New	+$5.84M	0.26%	68

Other funds holding AXNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Armistice Capital's AXNX Position: Q1 2022 in Review

Armistice Capital sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2022, closing a stake of 388,000 shares — an estimated $21.7M sold.

Armistice Capital first reported a position in AXNX in Q3 2020 and held it in 5 quarters. The position peaked at $25M in Q1 2021. 187 funds tracked by Wall St. Rank hold AXNX as of Q1 2022.

Armistice Capital reported no remaining Axonics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Armistice Capital sold 388,000 Axonics, Inc. Common Stock shares in Q1 2022, an estimated $21.7M.
Armistice Capital first reported a position in Axonics, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
Armistice Capital's Axonics, Inc. Common Stock position peaked at $25M in Q1 2021.
187 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2022.

Based on Armistice Capital's 13F filing for Q1 2022, filed 16 May 2022.